13F Holdings
中文EN

EDVA Endovia Health Sciences, Inc.

Beverages · NYSE · SEC CIK 1553788 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY79.3%
TTM net income YoY33.3%
TTM EPS YoY89.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin-13.6%
Operating margin3,741.9%
Net margin4,787.7%
FCF margin—
EBITDA margin3,756.9%

Returns

ROE—
ROA-148.3%
ROIC (approx.)—
Asset turnover-0.03x

Leverage & solvency

Liabilities / assets1,563.2%
Debt / equity—
Current ratio0.05x
Interest coverage-5.67x

Cash quality & payout

Operating cash flow / net income0.31x
Accruals ratio-101.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$73,066$801,273$18.85M$18.09M$11.32M
Cost of revenue—$3.80M$13.28M$12.17M$7.40M
Gross profit$16,898-$119,797$5.57M$5.92M$3.92M
Operating income-$14.19M-$9.90M-$15.29M-$21.39M-$29.08M
Interest expense$2.52M$3.70M$1.86M$251,497$442,807
Income tax$0$0$0$0$0
Net income-$25.23M-$23.76M-$21.00M-$21.69M-$29.05M
EBITDA-$14.18M-$9.50M-$14.74M-$20.46M-$28.97M
EPS (basic)-11.97-17.68——-1.02
EPS (diluted)-11.97-17.68——-1.02
Weighted avg. shares (diluted)2.18M1.34M1.06M37.39M28.90M
Banking
Net interest income-$2.52M-$3.70M-$1.85M—-$442,807
Balance sheet
Cash & equivalents$281,435$15,346$167,168$4.43M$4.18M
Receivables$15,748$191,991$890,631$1.81M$1.11M
Inventory$33,538$319,104$2.25M$3.72M$1.92M
Current assets$631,993$1.90M$3.98M$10.66M$8.34M
PP&E, net$12,926$22,210$349,802$489,597$569,785
Goodwill——$256,823$256,823$256,823
Intangibles——$4.46M$4.85M$5.60M
Total assets$965,694$2.76M$9.90M$17.30M$16.39M
Current liabilities$16.26M$19.37M$14.75M$4.97M$6.48M
Long-term debt$3,418$1.97M$457,656$2.54M$0
Total debt$3,418$1.97M$457,656$2.54M$0
Total liabilities$16.27M$21.39M$15.50M$7.98M$7.51M
Shareholders' equity-$15.30M-$18.63M-$5.61M$9.32M$8.87M
Net debt-$278,017$1.96M$290,488-$1.90M-$4.18M
Shares outstanding749,4501.67M1.11M41.09M33.60M
Cash flow statement
Operating cash flow-$4.82M-$7.30M-$10.19M-$14.04M-$14.70M
Capital expenditure—$3,235$14,113$102,698$0
Free cash flow—-$7.31M-$10.20M-$14.14M-$14.70M
Investing cash flow—-$3,235-$14,113-$102,698$0
Financing cash flow$5.10M$7.54M$6.15M$14.45M$19.01M
Depreciation & amortization$9,284$401,602$545,977$936,020$111,567
Stock-based compensation$8.62M$2.36M$1.17M$7.41M$3.97M

Free plan shows the latest 5 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.